ADPT vs MAS · rev $142.4M vs P/E 18, rev $7.56B
Adaptive Biotechnologies Corp (ADPT) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Adaptive Biotechnologies Corp (ADPT) is a diagnostics & research company listed on NASDAQ.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported ADPT revenue for 2026-06-30 was $142.4M. Net income was -$59.8M. ADPT currently screens at market cap $2.69B.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
ADPT currently screens at market cap $2.69B. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the ADPT and MAS stock pages for the full models.
Not investment advice.